Since the late 1980’s there has been an increasing trend in the proportion of FQ-resistant strains of members of the genus Campylobacter isolated from both clinical samples [ 11–13 ] and livestock, where FQs (particularly enrofloxacin) are frequently used to treat animals in intensive production [ 5, 7, 9, 12, 14 ].
1
—
—